KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Dividends Paid - Common (2016 - 2025)

Historic Dividends Paid - Common for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to $8.7 million.

  • Chemed's Dividends Paid - Common rose 1558.7% to $8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.7 million, marking a year-over-year increase of 1966.47%. This contributed to the annual value of $27.1 million for FY2024, which is 1527.53% up from last year.
  • Per Chemed's latest filing, its Dividends Paid - Common stood at $8.7 million for Q3 2025, which was up 1558.7% from $7.2 million recorded in Q2 2025.
  • Chemed's Dividends Paid - Common's 5-year high stood at $8.7 million during Q3 2025, with a 5-year trough of $5.3 million in Q1 2022.
  • Moreover, its 5-year median value for Dividends Paid - Common was $5.7 million (2023), whereas its average is $6.2 million.
  • Per our database at Business Quant, Chemed's Dividends Paid - Common tumbled by 211.51% in 2022 and then surged by 2408.02% in 2024.
  • Chemed's Dividends Paid - Common (Quarter) stood at $5.6 million in 2021, then grew by 1.21% to $5.6 million in 2022, then rose by 7.64% to $6.1 million in 2023, then grew by 23.81% to $7.5 million in 2024, then increased by 15.42% to $8.7 million in 2025.
  • Its last three reported values are $8.7 million in Q3 2025, $7.2 million for Q2 2025, and $7.3 million during Q1 2025.